Pathology News
admin

About admin@pathologynews.com

This author has not yet filled in any details.
So far admin@pathologynews.com has created 1088 blog entries.

May 2024

Quest Diagnostics and PathAI Collaboration to Revolutionize Pathology Diagnostics

2024-05-01T19:34:10+00:00

Transaction is part of wide-ranging collaboration to combine Quest's oncology expertise and scale with PathAI's AI and digital pathology innovations to speed diagnosis, improve quality and reduce costs Quest Diagnostics, a leader in diagnostic information services, and PathAI, a global provider of artificial intelligence-powered technology for pathology, today announced a multi-faceted collaboration designed to accelerate the adoption [...]

Quest Diagnostics and PathAI Collaboration to Revolutionize Pathology Diagnostics2024-05-01T19:34:10+00:00

April 2024

Diagnexia Accelerates Growth with Strategic Expansion within Exeter Science Park

2024-04-30T10:40:07+00:00

Diagnexia, the digital pathology diagnostics leader and a division of Deciphex, today unveiled its strategic relocation to a larger facility within Exeter Science Park. This move is a direct response to the increasing demand for Diagnexia's advanced histopathology services, emphasising the company's commitment to staying at the forefront of healthcare diagnostics innovation and efficiency.

Diagnexia Accelerates Growth with Strategic Expansion within Exeter Science Park2024-04-30T10:40:07+00:00

Sectra and Leica Biosystems First in the World to Gain FDA Clearance to Utilize DICOM Images for Pathology Diagnostics

2024-04-30T08:15:11+00:00

Sectra received its first FDA clearance during the pandemic, in 2020. The pandemic made the need and value of remote work even in the field of pathology obvious and has helped boost the adoption of digital pathology in the US. Today, the value of accessing, sharing and reviewing digital images is clear and the market for digital pathology in the US, as well as other countries, is growing rapidly.

Sectra and Leica Biosystems First in the World to Gain FDA Clearance to Utilize DICOM Images for Pathology Diagnostics2024-04-30T08:15:11+00:00

Leica Biosystems Receives FDA 510(k) Clearance for Aperio GT 450 DX Digital Pathology System with both SVS and Native DICOM

2024-04-29T10:30:17+00:00

Leica Biosystems is pleased to announce that its flagship digital pathology system, Aperio GT 450 DX, has received 510(k) clearance from the US Food and Drug Administration. Previously sold into the clinical market under an enforcement discretion due to the COVID-19 pandemic, Aperio GT 450 is proven technology that consistently delivers high-quality images at a fast turnaround time of < 32 sec/slide.

Leica Biosystems Receives FDA 510(k) Clearance for Aperio GT 450 DX Digital Pathology System with both SVS and Native DICOM2024-04-29T10:30:17+00:00

Hoag Health System Selects PathAI and the AISight Image Management System to Support the Transition To Digital and AI-enabled Pathology

2024-04-26T08:13:30+00:00

Enabling next-generation digital and AI pathology utilizing the latest technological advances

Hoag Health System Selects PathAI and the AISight Image Management System to Support the Transition To Digital and AI-enabled Pathology2024-04-26T08:13:30+00:00

Seeing Cancer with Color: Spectroscopic Imaging Platform Maps Tumor Landscape

2025-11-24T16:18:59+00:00

Cancer cells avoid detection by shielding themselves behind a complex molecular barricade of normal cells. This impenetrable tumor microenvironment hides cancer cells not only from the immune system but also from clinicians trying to diagnose and treat the disease.

Seeing Cancer with Color: Spectroscopic Imaging Platform Maps Tumor Landscape2025-11-24T16:18:59+00:00

How AI is Transforming Pathology in Developing Countries | Digital Pathology in Pakistan With Talat Zehra

2025-05-06T12:37:23+00:00

Dr. Zehra began her digital journey with a basic microscope equipped with an inbuilt camera, taking static images for telepathology and educational purposes. Despite lacking a scanner, she persisted in exploring AI applications on these images. Collaborating with vendors like Aiforia, she learned to annotate images and apply algorithms, leading to three published projects in peer-reviewed journals.

How AI is Transforming Pathology in Developing Countries | Digital Pathology in Pakistan With Talat Zehra2025-05-06T12:37:23+00:00

Understanding the Role of Artificial Intelligence in Imaging Cytometry

2024-04-25T08:07:36+00:00

Artificial Intelligence (AI) has emerged as a transformative force in numerous disciplines. This includes imaging cytometry. By integrating AI with image cytometry, remarkable advancements have been made, particularly in automating the analysis of cellular and tissue images.

Understanding the Role of Artificial Intelligence in Imaging Cytometry2024-04-25T08:07:36+00:00

Tribun Health, Winner of the I-Nov Competition of Bpifrance, Obtains Funding of Over €600,000 for Its Pathomix Project

2024-04-24T13:36:22+00:00

Tribun Health, a major player in software solutions for digital pathology, is delighted to announce its selection among the winners of the i-Nov Wave 11 competition organized by Bpifrance, as part of the France 2030 plan. This competition aims to support the accelerated emergence of innovative companies that are leaders in their field.

Tribun Health, Winner of the I-Nov Competition of Bpifrance, Obtains Funding of Over €600,000 for Its Pathomix Project2024-04-24T13:36:22+00:00

Deciphex Enters into Collaboration Agreement with Novartis to Advance AI in Preclinical Studies

2024-04-23T14:00:02+00:00

Deciphex, a Dublin-based digital pathology company, has entered into a Collaboration Agreement with Novartis to develop artificial intelligence (AI)-based approaches with potential to transform preclinical pathology assessments in drug discovery and development. The collaboration seeks to develop a suite of AI tools that streamline the pathology evaluation of toxicological and efficacy studies.

Deciphex Enters into Collaboration Agreement with Novartis to Advance AI in Preclinical Studies2024-04-23T14:00:02+00:00
Legal

Bioincyte Ltd is registered in the United Kingdom
under company number 13037659

Get in touch

© Copyright 2025, Bioincyte Ltd

Fields marked with an asterisk (*) are required.
By submitting you agree to our T&C and Privacy Policy

Go to Top